Skip to main content
Addgene

pDRM210 LGP (Luciferase GFP Puro)
(Plasmid #174722)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 174722 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pRRLSIN.cPPT.MND
  • Backbone size w/o insert (bp) 6685
  • Total vector size (bp) 9863
  • Vector type
    Mammalian Expression, Lentiviral, Luciferase
  • Selectable markers
    Puromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    30°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert 1

  • Gene/Insert name
    Firefly Luciferase
  • Alt name
    Luc
  • Species
    Photinus pyralis
  • Insert Size (bp)
    1650
  • Promoter MND
  • Tag / Fusion Protein
    • E2A linker (C terminal on insert)

Cloning Information for Gene/Insert 1

Gene/Insert 2

  • Gene/Insert name
    eGFP
  • Alt name
    Enhanced Green Fluorescent Protein
  • Species
    Aequorea victoria
  • Insert Size (bp)
    717
  • Promoter MND (off Luc-E2A)
  • Tag / Fusion Protein
    • F2A linker (C terminal on insert)

Cloning Information for Gene/Insert 2

Gene/Insert 3

  • Gene/Insert name
    pac
  • Alt name
    puromycin acetyl transferase/ PuroR
  • Species
    Streptomyces alboniger
  • Insert Size (bp)
    600
  • Promoter MND (off Luc-E2A-eGFP-F2A)

Cloning Information for Gene/Insert 3

Resource Information

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pDRM210 LGP (Luciferase GFP Puro) was a gift from Wayne Tilley (Addgene plasmid # 174722 ; http://n2t.net/addgene:174722 ; RRID:Addgene_174722)
  • For your References section:

    Selective inhibition of CDK9 in triple negative breast cancer. Mustafa EH, Laven-Law G, Kikhtyak Z, Nguyen V, Ali S, Pace AA, Iggo R, Kebede A, Noll B, Wang S, Winter JM, Dwyer AR, Tilley WD, Hickey TE. Oncogene. 2023 Nov 24. doi: 10.1038/s41388-023-02892-3. 10.1038/s41388-023-02892-3 PubMed 38001268